University of Minnesota. Driven to Discover.
In other developments, the HHS announced more funding for a rapid Ebola test.
One treatment is a new type of antiviral targeted for hospitalized patients, and the second is a monoclonal antibody.
A case update from the WHO showed a variety of exposure types, with some unknown.
A UC–Santa Cruz team has developed a chip-based method to directly detect Ebola.
Both the H3N2 and B strains will differ in next year's Southern Hemisphere trivalent flu vaccine.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.